During the last decade, the importance of the complement system has become evident in both clinical medicine and complement therapeutics. This increased interest means a more prominent need for assays to evaluate complement activity.
Activity markers are used to determine whether deficiencies, overactivation or dysregulation in the complement system are causing, or contributing to, a person's disease or condition.
In order to exactly measure such activation, assays for quantification of products formed during activation are required.
The Svar Complement activity markers give valuable intelligence in several situations where one might suspect that complement activation plays a role in the disorder. An important aspect when using complement activity markers to evaluate a pathological condition is only measure the specific activated protein. Therefore, the Svar assays for complement activity markers are developed to target the unique neoepitopes only presented at the complement component or complex when activated.